Board of directors in Medistim ASA has decided to sell 
25,000 Medistim shares to NOK 36 per share to CEO Kari 
Krogstad.  Kari Krogstad is paying NOK 900.000 for 
additional shares in Medistim. The share price at 
inception was NOK 44.8 and the shares will be 
transferred at this value. Medistim ASA had 221,000 
own shares and after the sale to Kari Krogstad this is 
reduced to 196,000 own shares. Kari Krogstad has after 
the last trade 80,000 shares in Medistim ASA.